Foresite Capital Management IV’s Cytokinetics CYTK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-545,101
| Closed | -$10.8M | – | 13 |
|
|
2021
Q2 | $10.8M | Sell |
545,101
-336,800
| -38% | -$6.67M | 1.46% | 9 |
|
|
2021
Q1 | $20.5M | Sell |
881,901
-554,091
| -39% | -$12.9M | 2.46% | 9 |
|
|
2020
Q4 | $29.8M | Sell |
1,435,992
-236,300
| -14% | -$4.91M | 3.24% | 8 |
|
|
2020
Q3 | $36.2M | Buy |
1,672,292
+65,000
| +4% | +$1.41M | 8.16% | 6 |
|
|
2020
Q2 | $37.9M | Sell |
1,607,292
-570,000
| -26% | -$13.4M | 18.45% | 2 |
|
|
2020
Q1 | $25.7M | Sell |
2,177,292
-221,678
| -9% | -$2.61M | 31.64% | 1 |
|
|
2019
Q4 | $25.5M | Buy |
2,398,970
+500,000
| +26% | +$5.3M | 10.98% | 4 |
|
|
2019
Q3 | $21.6M | Hold |
1,898,970
| – | – | 6.98% | 6 |
|
|
2019
Q2 | $21.4M | Buy |
1,898,970
+175,800
| +10% | +$1.98M | 6.04% | 5 |
|
|
2019
Q1 | $13.9M | Buy |
1,723,170
+1,548,022
| +884% | +$12.5M | 5.01% | 9 |
|
|
2018
Q4 | $1.11M | Buy |
+175,148
| New | +$1.11M | 0.51% | 18 |
|